Non ‐alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues
In conclusion, identifying HF patients at risk of NAFLD is a critically important issue. As soon as NAFLD is confirmed and its severity determined, patients should be proposed a management focused on symptoms and co‐morbidities.
Source: ESC Heart Failure - Category: Cardiology Authors: Romain Itier,
Maeva Guillaume,
Jean ‐Etienne Ricci,
François Roubille,
Nicolas Delarche,
François Picard,
Michel Galinier,
Jérôme Roncalli Tags: Review Source Type: research
More News: Alcoholism | Cardiology | Cardiovascular | Cirrhosis | Fatty Liver Disease (FLD) | Heart | Heart Failure | Hypertension | Insulin | Liver | Liver Disease | Metabolic Syndrome | Non-alcoholic Fatty Liver Diseases (NAFLD) | Study | Urology & Nephrology | Victoza